Blueprint Gains Approval for Cancer Drug, Shares Climbing

By |2020-10-20T14:51:44-04:00January 10th, 2020|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, In Depth Research, SanaCurrents, SanaCurrents Updates|Tags: |

The FDA approved the lead cancer drug from Blueprint Medicines [...]